Clinical trials: White Matter Hyperintensity
Alzheimer's Dementia
Cilostazol Augmentation Study in Dementia
The purpose of this study is to examine the effects of cilostazol augmentation in mild to moderate Alzheimer disease patients with subcortical white matter hyperintensities (WMHI) treated by donepezil.
- Trial name
- NCT01409564
- Testing
- Cilostazol
- Where
- South Korea
- Volunteers
- 46 people
- Sponsor
- Seoul National University Hospital